Cargando…

Evolution of the RebiSmart(®) Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multiple Sclerosis

BACKGROUND: The RebiSmart(®) electromechanical autoinjector supports people living with relapsing multiple sclerosis (MS) with their adherence to treatment with subcutaneous interferon beta-1a (sc IFN β-1a; Rebif(®)), a well-established and effective therapy. We report on the validation of the next-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yu-Ting, Will, Tamara, Wickham, Charlotte, Boeree, Petra, Jack, Dominic, Keiser, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423595/ https://www.ncbi.nlm.nih.gov/pubmed/37581193 http://dx.doi.org/10.2147/PPA.S414151

Ejemplares similares

An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart(®) injection device
por: Willis, Helen, et al.
Publicado: (2014)

Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study
por: Zecca, Chiara, et al.
Publicado: (2017)

Adherence to self-administering interferon-β1a using RebiSmart® device in Mexican patients with relapsing multiple sclerosis
por: Sauri-Suárez, Sergio, et al.
Publicado: (2020)

Seasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study
por: Deftereos, Spyros N., et al.
Publicado: (2018)

Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis
por: Fernández, O., et al.
Publicado: (2016)

Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart(®) injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis
por: Krol, Marieke, et al.
Publicado: (2017)

Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart(®) in patients with multiple sclerosis
por: Edo Solsona, María Dolores, et al.
Publicado: (2017)

Usability and Acceptability of the Abatacept Pre-Filled Autoinjector for the Subcutaneous Treatment of Rheumatoid Arthritis
por: Schiff, Michael, et al.
Publicado: (2016)

Adherence to Subcutaneous Interferon Beta-1a in Multiple Sclerosis Patients Receiving Periodic Feedback on Drug Use by Discussion of Readouts of Their Rebismart(®) Injector: Results of the Prospective Cohort Study REBIFLECT
por: Rieckmann, Peter, et al.
Publicado: (2022)

Patient satisfaction with the BETACONNECT™ autoinjector for interferon beta-1b
por: Weller, Ivonne, et al.
Publicado: (2015)

Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™)
por: Ziemssen, Tjalf, et al.
Publicado: (2015)

Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical Autoinjectors
por: Barone, Donald A., et al.
Publicado: (2016)

Evaluation of Usability and Acceptance of a New Autoinjector Intended for Methotrexate Subcutaneous Self-Administration in the Management of Rheumatoid Arthritis
por: Hudry, Christophe, et al.
Publicado: (2017)

Adherence with epinephrine autoinjector prescriptions in primary care
por: Abrams, Elissa M., et al.
Publicado: (2017)

Adherence to adrenaline autoinjector prescriptions in patients with anaphylaxis
por: Parke, Louise, et al.
Publicado: (2019)

Pharmacokinetics of Subcutaneous Dupilumab Injection With an Autoinjector Device or Prefilled Syringe
por: Cohen, Yehuda Z., et al.
Publicado: (2022)

Smart electromechanical systems
por: Gorodetskiy, Andrey
Publicado: (2016)

Autoinjector – A smart device for emergency cum personal therapy
por: Roy, Anitha, et al.
Publicado: (2021)

Evaluation of a novel autoinjector for subcutaneous self-administration of belimumab in systemic lupus erythematosus
por: Sheikh, Saira Z., et al.
Publicado: (2016)

Potential Benefits of the Self-Administration of Subcutaneous Methotrexate with Autoinjector Devices for Patients: A Review
por: Tornero Molina, Jesús, et al.
Publicado: (2021)

Smart electromechanical systems: situational control
por: Gorodetskiy, Andrey E, et al.
Publicado: (2019)

Autoinjectors for administration of interferon beta-1b in multiple sclerosis: patient preferences and the ExtaviPro™ 30G and Betacomfort(®) devices
por: Thakur, Kunal, et al.
Publicado: (2013)

Real-World Assessment of Interferon-β-1b and Interferon-β-1a Adherence Before and After the Introduction of the BETACONNECT(®) Autoinjector: A Retrospective Cohort Study
por: Butler, Oisín, et al.
Publicado: (2021)

A Pharmacokinetic Bioequivalence Study of Fremanezumab Administered Subcutaneously Using an Autoinjector and a Prefilled Syringe
por: Cherniakov, Irina, et al.
Publicado: (2021)

Improving adrenaline autoinjector adherence: A psychologically informed training for healthcare professionals
por: Mahoney, Béré, et al.
Publicado: (2019)

Results of a human factors experiment of the usability and patient acceptance of a new autoinjector in patients with rheumatoid arthritis
por: Schwarzenbach, Florence, et al.
Publicado: (2014)

Human Factors Usability and Validation Studies of a Glucagon Autoinjector in a Simulated Severe Hypoglycemia Rescue Situation
por: Valentine, Virginia, et al.
Publicado: (2019)

Improving epinephrine autoinjector usability and carriage frequency among patients at risk of anaphylaxis: a quality improvement initiative
por: Ziyar, Ahdad, et al.
Publicado: (2022)

Smart electromechanical systems the central nervous system
por: Gorodetskiy, Andrey, et al.
Publicado: (2017)

RebiQoL: A randomized trial of telemedicine patient support program for health-related quality of life and adherence in people with MS treated with Rebif
por: Landtblom, Anne-Marie, et al.
Publicado: (2019)

Adherence to subcutaneous interferon beta-1a treatment using an electronic injection device: a prospective open-label Scandinavian noninterventional study (the ScanSmart study)
por: Pedersen, Elena Didenko, et al.
Publicado: (2018)

The pharmacokinetics of epinephrine/adrenaline autoinjectors
por: Dreborg, Sten, et al.
Publicado: (2021)

Leveraging Dissolution by Autoinjector Designs
por: Spangardt, Christoph, et al.
Publicado: (2022)

Evaluation of performance, safety, subject acceptance, and compliance of a disposable autoinjector for subcutaneous injections in healthy volunteers
por: Berteau, Cecile, et al.
Publicado: (2010)

Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects
por: Struemper, Herbert, et al.
Publicado: (2015)

Patient Evaluation of Satisfaction and Outcomes with an Autoinjector for Self-Administration of Subcutaneous Belimumab in Patients with Systemic Lupus Erythematosus
por: Dashiell-Aje, Ebony, et al.
Publicado: (2017)

Usability of a new disposable autoinjector platform device: results of a formative study conducted with a broad user population
por: Lange, Jakob, et al.
Publicado: (2015)

Accidental Digital Ischemia by an Epinephrine Autoinjector
por: Nayaz, Mohamed, et al.
Publicado: (2023)

Outcomes of COVID-19 among patients treated with subcutaneous interferon beta-1a for multiple sclerosis
por: Freedman, Mark S., et al.
Publicado: (2021)

Electronic Smart Blister Packages to Monitor and Support Medication Adherence: A Usability Study
por: Izzah, Zamrotul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sep22io3obocvlpfafcip98d3o